Table 1 Study schedule

Visit

1

2

3

4

5

6

EDV

Visit window

−28 ~ 0 day

0

±14 days

±14 days

±14 days

±14 days

Informed consent

●

Demographic information and medical history

●

Inclusion/exclusion criteria

●

Physical examination

●

Randomization

●

Digital integrated healthcare platform application (Groups B, C)

●

●

●

●

●

●

Continuous glucose monitoring system application (Group C)

●

●

●

●

●

●

Continuous glucose monitoring system data collection (Group C)

●

●

●

●

●

●

Vital signs

●

●

●

●

●

●

●

Laboratory tests

●

●

●

●

●

●

●

Evaluation of hypoglycemia/severe hyperglycemia

●

●

●

●

●

Satisfaction questionnaire (DTSQ)

●

●

●

●

●

●

Digital integrated healthcare platform data collection (Group B, C)

●

●

●

●

●

●

Monitoring and intervention (Group C)

●

●

●

●

●

●

Adverse event report

●

●

●

●

●

●

Concomitant drugs

●

●

●

●

●

●

●